ALGS Earnings — Aligos Therapeutics, Inc. Common Stock Post-ER Performance | BigEarnings
ALGS — Aligos Therapeutics, Inc. Common Stock
XNAS · Healthcare · Biotechnology
Price$5.70
Market Cap$35.3M
P/E—
52W Range$5.12 – $13.69
Next Earnings2026-08-05
About Aligos Therapeutics, Inc. Common Stock
Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.
